Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys.
about
HIV-1 induced bystander apoptosisInfectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeysImportance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo.Characterization of primary isolate-like variants of simian-human immunodeficiency virusEnvelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virusA commonly recognized simian immunodeficiency virus Nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the prevalent major histocompatibility complex class I allele Mamu-A*02.Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication.Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymusPostnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge.Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression.Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.High frequency of virus-specific B lymphocytes in germinal centers of simian-human immunodeficiency virus-infected rhesus monkeysMolecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage.Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.Vaccination reduces simian-human immunodeficiency virus sequence reversion through enhanced viral controlIncreased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particlesThe efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection.Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteinsInfection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopesHIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropismGeneration of HIV-1 derivatives that productively infect macaque monkey lymphoid cells
P2860
Q22241221-DA69A4E4-DAF8-495D-AC94-1BBFFB43B4F4Q30329167-CCB2F12D-249C-4979-A196-10B3155BA823Q33640139-A9977D96-D82E-49EF-A744-F7C764C0BDBEQ33717525-5AF15BB8-661C-4562-A2C9-19F7DC79DEA1Q33725587-7E4D7771-5407-40F7-847C-D4DE9D3F713AQ33737656-36273185-ECA1-466D-8757-40A27C635E9FQ33783516-F7A75C71-26A5-4B93-AF0D-D6E4ABEDC37BQ33785114-84F95CC3-E03B-4EBF-A2E5-2CDF21566C18Q33787335-16E96BE5-1255-43D7-86BB-3FD67453EF07Q33794744-14813F4B-CFA9-423A-B208-2BEEA8F09921Q33802066-ACDAAA8D-B552-480D-A4CA-F039A4E37ADCQ33803217-EA79B29B-936F-4E06-A4D9-0E1121CEA526Q33813926-F57F329B-2DAF-4642-AD33-F612FD37C4C3Q33820014-E528ABC7-6CD8-4B54-B623-A0401BDCCB64Q33821658-4727E5EF-EAC9-474C-99A2-7D8AF59D82A3Q33825229-BF931E85-F9B2-4DC0-9311-9E6E720A6B6FQ33839485-D9AB2DA1-E0CD-4551-8D54-9DE37313B024Q33842020-1F5203C4-631D-4F06-867E-A4285EA235BBQ33847656-1E446641-5B1E-496E-91E4-EBAFE10E41E4Q33849755-692D7FCF-5B14-4256-81CA-8D2B642F860BQ33851415-3AF935F1-EA39-413C-A62D-CDBA2405E4E7Q33852768-9AEE40BA-FF0B-49FE-9A30-84D34425497CQ33854319-3436CF60-31BA-426C-A678-92863C65B39BQ33893395-1A5E996A-3033-4453-BA2A-F293D330954EQ33980469-E9BF6265-AE65-46F6-8AD1-AE6741076E49Q34008699-1E66A737-721F-41B3-90C1-F062BD95F4E9Q34069791-671054C0-5D19-45C4-A9F8-D38E3AE73253Q34337263-B1BB3AA6-6FB1-4554-96F6-34E2E58CEC6DQ34338411-9D672250-8ADF-4174-B7DA-A843CF78697DQ34339365-14FE6D52-EEAD-4BD5-9C75-A7EEA9A053C7Q34416586-CFC23ACB-D849-462F-89CD-2B58F6ADCD3AQ34464860-FFCF2ACC-9610-4574-9C0D-696A1C17AFF7Q34465510-EEAB7667-CFC2-42D9-A939-E62C1CEE2385Q34535707-413D8C0D-E01D-48BC-B948-19C135E885A0Q34552313-319190FB-85A7-4DBA-9B3E-A55F943AF4F2Q34648429-4EBDDFAE-3818-41F9-987A-749E05525A4EQ34721189-BDAB39DD-1ABE-46B5-BF5B-D355CD4168C5Q34791232-547D17FF-1FC6-4040-A365-0EB33AB31BD9Q35076868-F4D62D1E-B143-42F5-9424-89E0C1663F91Q35108494-DEA8D4E4-8A77-48A2-AB4A-45CADFDBCBDC
P2860
Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Characterization of molecularl ...... e depletion in rhesus monkeys.
@ast
Characterization of molecularl ...... e depletion in rhesus monkeys.
@en
type
label
Characterization of molecularl ...... e depletion in rhesus monkeys.
@ast
Characterization of molecularl ...... e depletion in rhesus monkeys.
@en
prefLabel
Characterization of molecularl ...... e depletion in rhesus monkeys.
@ast
Characterization of molecularl ...... e depletion in rhesus monkeys.
@en
P2093
P2860
P1433
P1476
Characterization of molecularl ...... e depletion in rhesus monkeys.
@en
P2093
G B Karlsson
J Sodroski
K A Reimann
M K Axthelm
N L Letvin
P2860
P304
P407
P50
P577
1997-06-01T00:00:00Z